{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:18:05Z","timestamp":1792466285234,"version":"4.5.0"},"reference-count":123,"publisher":"Elsevier","isbn-type":[{"value":"9780128024614","type":"print"}],"license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"DOI":"10.1016\/bs.pmbts.2014.10.005","type":"book-chapter","created":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T22:20:56Z","timestamp":1417472456000},"page":"141-166","source":"Crossref","is-referenced-by-count":48,"title":["A Game of Numbers"],"prefix":"10.1016","author":[{"given":"Theodore C.","family":"Pierson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.pmbts.2014.10.005_bb0005","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2013.04.015","article-title":"Resurgence of West Nile neurologic disease in the United States in 2012: what happened? What needs to be done?","volume":"99","author":"Beasley","year":"2013","journal-title":"Antivir Res"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0015","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1016\/j.vaccine.2011.09.114","article-title":"Flaviviruses and flavivirus vaccines","volume":"30","author":"Heinz","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0020","series-title":"Vaccines","article-title":"Yellow fever vaccine","author":"Monath","year":"2008"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0025","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1586\/14760584.4.4.553","article-title":"Yellow fever vaccine","volume":"4","author":"Monath","year":"2005","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0030","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4269\/ajtmh.2012.11-0525","article-title":"The safety of yellow fever vaccine 17D or 17DD in children, pregnant women, HIV+ individuals, and older persons: systematic review","volume":"86","author":"Thomas","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0035","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.meegid.2012.08.015","article-title":"Evolutionary and ecological factors underlying the tempo and distribution of yellow fever virus activity","volume":"13","author":"Carrington","year":"2013","journal-title":"Infect Genet Evol"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0040","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1586\/erv.11.7","article-title":"New Japanese encephalitis vaccines: alternatives to production in mouse brain","volume":"10","author":"Halstead","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0045","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1586\/14760584.2013.835638","article-title":"IXIARO updated: overview of clinical trials and developments with the inactivated vaccine against Japanese encephalitis","volume":"12","author":"Jelinek","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0050","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1586\/erv.10.139","article-title":"IMOJEV((R)): a Yellow fever virus-based novel Japanese encephalitis vaccine","volume":"9","author":"Appaiahgari","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0055","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3201\/eid1901.120458","article-title":"Vaccination and tick-borne encephalitis, central Europe","volume":"19","author":"Heinz","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0060","doi-asserted-by":"crossref","first-page":"7559","DOI":"10.1016\/j.vaccine.2007.08.024","article-title":"Field effectiveness of vaccination against tick-borne encephalitis","volume":"25","author":"Heinz","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0065","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2217\/imt.10.93","article-title":"Vaccines and immunotherapeutics for the prevention and treatment of infections with West Nile virus","volume":"3","author":"Beasley","year":"2011","journal-title":"Immunotherapy"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(14)61060-6","article-title":"Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial","author":"Capeding","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0075","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1016\/j.vaccine.2005.07.002","article-title":"Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2\u20133 September, 2004","volume":"23","author":"Hombach","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0080","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrmicro2950","article-title":"West Nile virus infection and immunity","volume":"11","author":"Suthar","year":"2013","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0085","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4269\/ajtmh.1952.1.30","article-title":"Research on dengue during World War II","volume":"1","author":"Sabin","year":"1952","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0090","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s00705-013-1645-3","article-title":"Secondary infection as a risk factor for dengue hemorrhagic fever\/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection","volume":"158","author":"Guzman","year":"2013","journal-title":"Arch Virol"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0095","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/B978-0-12-800098-4.00007-6","article-title":"Dengue virus vaccine development","volume":"88","author":"Yauch","year":"2014","journal-title":"Adv Virus Res"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0100","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0065-3527(03)60011-4","article-title":"Neutralization and antibody-dependent enhancement of dengue viruses","volume":"60","author":"Halstead","year":"2003","journal-title":"Adv Virus Res"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0105","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.chom.2007.03.002","article-title":"The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection","volume":"1","author":"Pierson","year":"2007","journal-title":"Cell Host Microbe"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0110","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0882-4010(87)90056-8","article-title":"Profiles of antibody-dependent enhancement of dengue virus type 2 infection","volume":"3","author":"Morens","year":"1987","journal-title":"Microb Pathog"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0115","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/infdis\/140.4.527","article-title":"In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody","volume":"140","author":"Halstead","year":"1979","journal-title":"J Infect Dis"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0120","doi-asserted-by":"crossref","first-page":"e1000790","DOI":"10.1371\/journal.ppat.1000790","article-title":"Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification","volume":"6","author":"Balsitis","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0125","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.chom.2010.01.004","article-title":"Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease","volume":"7","author":"Zellweger","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0130","doi-asserted-by":"crossref","first-page":"9422","DOI":"10.1073\/pnas.0703498104","article-title":"Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention","volume":"104","author":"Goncalvez","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0135","doi-asserted-by":"crossref","first-page":"e1004031","DOI":"10.1371\/journal.ppat.1004031","article-title":"First experimental in vivo model of enhanced dengue disease severity through maternally acquired heterotypic dengue antibodies","volume":"10","author":"Ng","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.micinf.2010.09.005","article-title":"Molecular mechanisms involved in the early steps of flavivirus cell entry","volume":"13","author":"Kaufmann","year":"2011","journal-title":"Microbes Infect"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0145","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.mib.2008.06.004","article-title":"Structural proteomics of dengue virus","volume":"11","author":"Perera","year":"2008","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0150","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/375291a0","article-title":"The envelope glycoprotein from tick-borne encephalitis virus at 2A resolution","volume":"375","author":"Rey","year":"1995","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0155","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nm0897-866","article-title":"Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate","volume":"3","author":"Chen","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0160","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1128\/JVI.06072-11","article-title":"Crystal structure of the Japanese encephalitis virus envelope protein","volume":"86","author":"Luca","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0165","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1126\/science.1153263","article-title":"The flavivirus precursor membrane-envelope protein complex: structure and maturation","volume":"319","author":"Li","year":"2008","journal-title":"Science"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0170","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1128\/JVI.75.9.4268-4275.2001","article-title":"Mutational evidence for an internal fusion peptide in flavivirus envelope protein E","volume":"75","author":"Allison","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0175","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1093\/emboj\/cdg270","article-title":"Structures of immature flavivirus particles","volume":"22","author":"Zhang","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0180","doi-asserted-by":"crossref","first-page":"6141","DOI":"10.1128\/JVI.00037-07","article-title":"Structure of immature West Nile virus","volume":"81","author":"Zhang","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0185","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1099\/vir.0.18723-0","article-title":"Cleavage of protein prM is necessary for infection of BHK-21 cells by tick-borne encephalitis virus","volume":"84","author":"Elshuber","year":"2003","journal-title":"J Gen Virol"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0190","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1099\/vir.0.015255-0","article-title":"Characterization of the functional requirements of West Nile virus membrane fusion","volume":"91","author":"Moesker","year":"2010","journal-title":"J Gen Virol"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0195","doi-asserted-by":"crossref","first-page":"12101","DOI":"10.1128\/JVI.01637-09","article-title":"Association of the pr peptides with dengue virus at acidic pH blocks membrane fusion","volume":"83","author":"Yu","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0200","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1126\/science.1153264","article-title":"Structure of the immature dengue virus at low pH primes proteolytic maturation","volume":"319","author":"Yu","year":"2008","journal-title":"Science"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0205","doi-asserted-by":"crossref","first-page":"8475","DOI":"10.1128\/JVI.71.11.8475-8481.1997","article-title":"Proteolytic activation of tick-borne encephalitis virus by furin","volume":"71","author":"Stadler","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0210","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(02)00660-8","article-title":"Structure of dengue virus: implications for flavivirus organization, maturation, and fusion","volume":"108","author":"Kuhn","year":"2002","journal-title":"Cell"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0215","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nature03956","article-title":"Structural basis of West Nile virus neutralization by a therapeutic antibody","volume":"437","author":"Nybakken","year":"2005","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0220","doi-asserted-by":"crossref","first-page":"12400","DOI":"10.1073\/pnas.0603488103","article-title":"West Nile virus in complex with the Fab fragment of a neutralizing monoclonal antibody","volume":"103","author":"Kaufmann","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0225","doi-asserted-by":"crossref","first-page":"139ra183","DOI":"10.1126\/scitranslmed.3003888","article-title":"The structural basis for serotype-specific neutralization of dengue virus by a human antibody","volume":"4","author":"Teoh","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0230","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/emmm.201303404","article-title":"A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface","volume":"6","author":"Fibriansah","year":"2014","journal-title":"EMBO Mol Med"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0235","doi-asserted-by":"crossref","first-page":"7439","DOI":"10.1073\/pnas.1200566109","article-title":"Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions","volume":"109","author":"de Alwis","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0240","doi-asserted-by":"crossref","first-page":"18950","DOI":"10.1073\/pnas.1011036107","article-title":"Neutralization of West Nile virus by cross-linking of its surface proteins with Fab fragments of the human monoclonal antibody CR4354","volume":"107","author":"Kaufmann","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0245","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.chom.2010.08.007","article-title":"The human immune response to dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity","volume":"8","author":"Beltramello","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0250","doi-asserted-by":"crossref","first-page":"e00873","DOI":"10.1128\/mBio.00873-13","article-title":"The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein","volume":"4","author":"Smith","year":"2013","journal-title":"mBio"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0255","doi-asserted-by":"crossref","first-page":"e1447","DOI":"10.1371\/journal.pntd.0001447","article-title":"Analysis of epitopes on dengue virus envelope protein recognized by monoclonal antibodies and polyclonal human sera by a high throughput assay","volume":"6","author":"Lin","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0260","doi-asserted-by":"crossref","first-page":"e4991","DOI":"10.1371\/journal.pone.0004991","article-title":"Humoral immune responses of dengue fever patients using epitope-specific serotype-2 virus-like particle antigens","volume":"4","author":"Crill","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0265","doi-asserted-by":"crossref","first-page":"8826","DOI":"10.1128\/JVI.01314-13","article-title":"Functional analysis of antibodies against dengue virus type 4 reveals strain-dependent epitope exposure that impacts neutralization and protection","volume":"87","author":"Sukupolvi-Petty","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0270","doi-asserted-by":"crossref","first-page":"e1188","DOI":"10.1371\/journal.pntd.0001188","article-title":"In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection","volume":"5","author":"de Alwis","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0275","doi-asserted-by":"crossref","first-page":"10630","DOI":"10.1128\/JVI.01190-10","article-title":"Genotype-specific neutralization and protection by antibodies against dengue virus type 3","volume":"84","author":"Brien","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0280","first-page":"109","article-title":"A model for neutralization of viruses based on antibody coating of the virion surface","volume":"260","author":"Burton","year":"2001","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0285","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0042-6822(56)90017-4","article-title":"A study of the basic aspects of neutralization of two animal viruses, western equine encephalitis virus and poliomyelitis virus","volume":"2","author":"Dulbecco","year":"1956","journal-title":"Virology"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0290","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/0042-6822(87)90466-1","article-title":"Quantitative relationships between an influenza virus and neutralizing antibody","volume":"159","author":"Taylor","year":"1987","journal-title":"Virology"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/0022-1317-38-1-1","article-title":"A multi-hit model for the neutralization of animal viruses","volume":"38","author":"Della-Porta","year":"1978","journal-title":"J Gen Virol"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0300","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nm1240","article-title":"Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus","volume":"11","author":"Oliphant","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0305","doi-asserted-by":"crossref","first-page":"e1002111","DOI":"10.1371\/journal.ppat.1002111","article-title":"A dynamic landscape for antibody binding modulates antibody-mediated neutralization of West Nile virus","volume":"7","author":"Dowd","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0310","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.chom.2007.04.001","article-title":"Antibodies to West Nile virus: a double-edged sword","volume":"1","author":"Klasse","year":"2007","journal-title":"Cell Host Microbe"},{"issue":"pt 1","key":"10.1016\/bs.pmbts.2014.10.005_bb0315","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1099\/0022-1317-70-1-37","article-title":"Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera","volume":"70","author":"Calisher","year":"1989","journal-title":"J Gen Virol"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0320","first-page":"469","article-title":"Antigenic classification and taxonomy of flaviviruses (family Flaviviridae) emphasizing a universal system for the taxonomy of viruses causing tick-borne encephalitis","volume":"32","author":"Calisher","year":"1988","journal-title":"Acta Virol"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0325","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nsmb.1382","article-title":"Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins","volume":"15","author":"Lok","year":"2008","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0330","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.2174\/156802611798808505","article-title":"Targeting HIV-1 gp41 in close proximity to the membrane using antibody and other molecules","volume":"11","author":"Gach","year":"2011","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0335","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.2174\/138161210794079182","article-title":"Antibody epitope exposure and neutralization of HIV-1","volume":"16","author":"Pantophlet","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0340","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.virol.2005.10.030","article-title":"A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection","volume":"346","author":"Pierson","year":"2006","journal-title":"Virology"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0345","doi-asserted-by":"crossref","first-page":"5967","DOI":"10.1128\/JVI.72.7.5967-5977.1998","article-title":"Encapsidation of the flavivirus Kunjin replicon RNA by using a complementation system providing Kunjin virus structural proteins in trans","volume":"72","author":"Khromykh","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0350","doi-asserted-by":"crossref","first-page":"e1000060","DOI":"10.1371\/journal.ppat.1000060","article-title":"Maturation of West Nile virus modulates sensitivity to antibody-mediated neutralization","volume":"4","author":"Nelson","year":"2008","journal-title":"PLoS Pathog"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0355","doi-asserted-by":"crossref","first-page":"7210","DOI":"10.1128\/JVI.03690-13","article-title":"Mechanism and significance of cell type-dependent neutralization of flaviviruses","volume":"88","author":"Mukherjee","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0360","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1084\/jem.146.1.201","article-title":"Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody","volume":"146","author":"Halstead","year":"1977","journal-title":"J Exp Med"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0365","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/282509a0","article-title":"Antibody-mediated enhancement of Flavivirus replication in macrophage-like cell lines","volume":"282","author":"Peiris","year":"1979","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0370","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/289189a0","article-title":"Monoclonal anti-Fc receptor IgG blocks antibody enhancement of viral replication in macrophages","volume":"289","author":"Peiris","year":"1981","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0375","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.chom.2009.09.003","article-title":"Complement protein C1q reduces the stoichiometric threshold for antibody-mediated neutralization of West Nile virus","volume":"6","author":"Mehlhop","year":"2009","journal-title":"Cell Host Microbe"},{"issue":"pt 8","key":"10.1016\/bs.pmbts.2014.10.005_bb0380","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1099\/0022-1317-65-8-1261","article-title":"Flavivirus infection enhancement in macrophages: radioactive and biological studies on the effect of antibody on viral fate","volume":"65","author":"Gollins","year":"1984","journal-title":"J Gen Virol"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0385","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.virol.2011.08.026","article-title":"Infection and activation of human peripheral blood monocytes by dengue viruses through the mechanism of antibody-dependent enhancement","volume":"421","author":"Sun","year":"2011","journal-title":"Virology"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0390","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S1473-3099(10)70166-3","article-title":"Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes","volume":"10","author":"Halstead","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0395","doi-asserted-by":"crossref","first-page":"8828","DOI":"10.1128\/JVI.00606-08","article-title":"Characterization of dengue virus complex-specific neutralizing epitopes on envelope protein domain III of dengue 2 virus","volume":"82","author":"Gromowski","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0400","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.virol.2007.05.042","article-title":"Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus","volume":"366","author":"Gromowski","year":"2007","journal-title":"Virology"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0405","series-title":"Molecular Virology and Control of Flaviviruses","article-title":"Antibody therapeutics against flaviviruses","author":"Diamond","year":"2012"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0410","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1126\/science.1185181","article-title":"Cross-reacting antibodies enhance dengue virus infection in humans","volume":"328","author":"Dejnirattisai","year":"2010","journal-title":"Science"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0415","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.str.2012.01.001","article-title":"Mechanism of dengue virus broad cross-neutralization by a monoclonal antibody","volume":"20","author":"Cockburn","year":"2012","journal-title":"Structure"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0420","doi-asserted-by":"crossref","first-page":"e1002930","DOI":"10.1371\/journal.ppat.1002930","article-title":"Structural basis of differential neutralization of DENV-1 genotypes by an antibody that recognizes a cryptic epitope","volume":"8","author":"Austin","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0425","doi-asserted-by":"crossref","first-page":"9557","DOI":"10.1128\/JVI.00080-06","article-title":"Cryptic properties of a cluster of dominant flavivirus cross-reactive antigenic sites","volume":"80","author":"Stiasny","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0430","doi-asserted-by":"crossref","first-page":"12149","DOI":"10.1128\/JVI.01732-06","article-title":"Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein","volume":"80","author":"Oliphant","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0435","doi-asserted-by":"crossref","first-page":"e1004072","DOI":"10.1371\/journal.ppat.1004072","article-title":"Potent dengue virus neutralization by a therapeutic antibody with low monovalent affinity requires bivalent engagement","volume":"10","author":"Edeling","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0440","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1128\/JVI.02273-12","article-title":"Mechanistic study of broadly neutralizing human monoclonal antibodies against dengue virus that target the fusion loop","volume":"87","author":"Costin","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0445","doi-asserted-by":"crossref","first-page":"8482","DOI":"10.1128\/JVI.00660-09","article-title":"Impact of quaternary organization on the antigenic structure of the tick-borne encephalitis virus envelope glycoprotein E","volume":"83","author":"Kiermayr","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0450","doi-asserted-by":"crossref","first-page":"13729","DOI":"10.1128\/JVI.02340-13","article-title":"The Fc region of an antibody impacts the neutralization of West Nile viruses in different maturation states","volume":"87","author":"Lee","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0455","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/jmv.1890450417","article-title":"Antibodies that block virus attachment to Vero cells are a major component of the human neutralizing antibody response against dengue virus type 2","volume":"45","author":"He","year":"1995","journal-title":"J Med Virol"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0460","doi-asserted-by":"crossref","first-page":"11526","DOI":"10.1128\/JVI.01041-07","article-title":"Probing the flavivirus membrane fusion mechanism by using monoclonal antibodies","volume":"81","author":"Stiasny","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0465","doi-asserted-by":"crossref","first-page":"e1000453","DOI":"10.1371\/journal.ppat.1000453","article-title":"A therapeutic antibody against West Nile virus neutralizes infection by blocking fusion within endosomes","volume":"5","author":"Thompson","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0470","doi-asserted-by":"crossref","first-page":"e1000672","DOI":"10.1371\/journal.ppat.1000672","article-title":"Capturing a flavivirus pre-fusion intermediate","volume":"5","author":"Kaufmann","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0475","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.virol.2010.12.020","article-title":"Antibody-mediated neutralization of flaviviruses: a reductionist view","volume":"411","author":"Dowd","year":"2011","journal-title":"Virology"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0480","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.coviro.2012.02.011","article-title":"Degrees of maturity: the complex structure and biology of flaviviruses","volume":"2","author":"Pierson","year":"2012","journal-title":"Curr Opin Virol"},{"issue":"pt 2","key":"10.1016\/bs.pmbts.2014.10.005_bb0485","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1099\/0022-1317-74-2-175","article-title":"Processing of the dengue virus type 2 proteins prM and C-prM","volume":"74","author":"Murray","year":"1993","journal-title":"J Gen Virol"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0490","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1128\/JVI.80.3.1290-1301.2006","article-title":"West Nile virus discriminates between DC-SIGN and DC-SIGNR for cellular attachment and infection","volume":"80","author":"Davis","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0495","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/0042-6822(92)90267-S","article-title":"The Murray Valley encephalitis virus prM protein confers acid resistance to virus particles and alters the expression of epitopes within the R2 domain of E glycoprotein","volume":"191","author":"Guirakhoo","year":"1992","journal-title":"Virology"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0500","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/embor.2011.75","article-title":"Maturation of flaviviruses starts from one or more icosahedrally independent nucleation centres","volume":"12","author":"Plevka","year":"2011","journal-title":"EMBO Rep"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0505","doi-asserted-by":"crossref","first-page":"8353","DOI":"10.1128\/JVI.00696-10","article-title":"Influence of pr-M cleavage on the heterogeneity of extracellular dengue virus particles","volume":"84","author":"Junjhon","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0510","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1038\/emboj.2009.245","article-title":"Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody","volume":"28","author":"Cherrier","year":"2009","journal-title":"EMBO J"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0515","doi-asserted-by":"crossref","first-page":"e1003761","DOI":"10.1371\/journal.ppat.1003761","article-title":"The type-specific neutralizing antibody response elicited by a dengue vaccine candidate is focused on two amino acids of the envelope protein","volume":"9","author":"VanBlargan","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0520","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1126\/science.1158818","article-title":"Biochemistry. How do proteins interact?","volume":"320","author":"Boehr","year":"2008","journal-title":"Science"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0525","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1006\/jmbi.1997.1542","article-title":"Influence of an antiviral compound on the temperature dependence of viral protein flexibility and packing: a molecular dynamics study","volume":"276","author":"Phelps","year":"1998","journal-title":"J Mol Biol"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0530","doi-asserted-by":"crossref","first-page":"6774","DOI":"10.1073\/pnas.95.12.6774","article-title":"Antiviral agent blocks breathing of the common cold virus","volume":"95","author":"Lewis","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0535","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1074\/jbc.273.2.673","article-title":"Evidence of viral capsid dynamics using limited proteolysis and mass spectrometry","volume":"273","author":"Bothner","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0540","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1128\/JVI.68.6.3965-3970.1994","article-title":"Poliovirus neutralization by antibodies to internal epitopes of VP4 and VP1 results from reversible exposure of these sequences at physiological temperature","volume":"68","author":"Li","year":"1994","journal-title":"J Virol"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0545","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01140-14","article-title":"Combined effects of the structural heterogeneity and dynamics of flaviviruses on antibody recognition","author":"Dowd","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0550","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/ni1113","article-title":"The complement system in regulation of adaptive immunity","volume":"5","author":"Carroll","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0555","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.virol.2009.08.019","article-title":"Complement modulates pathogenesis and antibody-dependent neutralization of West Nile virus infection through a C5-independent mechanism","volume":"393","author":"Mehlhop","year":"2009","journal-title":"Virology"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0560","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1128\/JVI.01797-08","article-title":"Vaccinia virus extracellular enveloped virion neutralization in vitro and protection in vivo depend on complement","volume":"83","author":"Benhnia","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0565","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.virol.2006.05.008","article-title":"Enhancement of neutralizing activity of influenza virus-specific antibodies by serum components","volume":"352","author":"Mozdzanowska","year":"2006","journal-title":"Virology"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0570","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.virol.2014.05.004","article-title":"The neutralizing capacity of antibodies elicited by parainfluenza virus infection of African Green Monkeys is dependent on complement","volume":"460\u2013461","author":"Mayer","year":"2014","journal-title":"Virology"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0575","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.virol.2009.09.024","article-title":"Dengue virus neutralization is modulated by IgG antibody subclass and Fcgamma receptor subtype","volume":"394","author":"Rodrigo","year":"2009","journal-title":"Virology"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0580","doi-asserted-by":"crossref","first-page":"e1003157","DOI":"10.1371\/journal.ppat.1003157","article-title":"Therapeutic efficacy of antibodies lacking Fcgamma receptor binding against lethal dengue virus infection is due to neutralizing potency and blocking of enhancing antibodies [corrected]","volume":"9","author":"Williams","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0585","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1128\/AAC.00147-07","article-title":"Defining limits of treatment with humanized neutralizing monoclonal antibody for West Nile virus neurological infection in a hamster model","volume":"51","author":"Morrey","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0590","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1073\/pnas.1317350111","article-title":"Dengue virus envelope protein domain I\/II hinge determines long-lived serotype-specific dengue immunity","volume":"111","author":"Messer","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0595","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.virol.2012.03.003","article-title":"Antibodies targeting dengue virus envelope domain III are not required for serotype-specific protection or prevention of enhancement in vivo","volume":"429","author":"Williams","year":"2012","journal-title":"Virology"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0600","doi-asserted-by":"crossref","first-page":"11828","DOI":"10.1128\/JVI.00643-07","article-title":"Induction of epitope-specific neutralizing antibodies against West Nile virus","volume":"81","author":"Oliphant","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0605","doi-asserted-by":"crossref","first-page":"e99881","DOI":"10.1371\/journal.pone.0099881","article-title":"Transplanting supersites of HIV-1 vulnerability","volume":"9","author":"Zhou","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/bs.pmbts.2014.10.005_bb0610","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nature12966","article-title":"Proof of principle for epitope-focused vaccine design","volume":"507","author":"Correia","year":"2014","journal-title":"Nature"},{"issue":"6","key":"10.1016\/bs.pmbts.2014.10.005_bb9000","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.chom.2007.09.015","article-title":"Complement protein C1q inhibits antibody-dependent enhancement of flavivirus infection in an IgG subclass-specific manner","volume":"2","author":"Mehlhop","year":"2007","journal-title":"Cell Host Microbe."}],"container-title":["Progress in Molecular Biology and Translational Science","The Molecular Basis of Viral Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117314000064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117314000064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T11:51:54Z","timestamp":1598529114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877117314000064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"ISBN":["9780128024614"],"references-count":123,"URL":"https:\/\/doi.org\/10.1016\/bs.pmbts.2014.10.005","relation":{},"ISSN":["1877-1173"],"issn-type":[{"value":"1877-1173","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}